The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis
Abstract
Purpose To develop a strategy to identify cases of endogenous subclinical hyperthyroidism and free triiodothyronine (free T3) thyrotoxicosis in otherwise healthy ambulatory patients.Patients and methods In a retrospective study we reviewed the records of ambulatory patients who had thyroid stimulating hormone (TSH) levels determined between October 1, 1991 and August 31, 1992. Each patient also had a simultaneous free thyroxine (free T4) measurement. Patients were excluded from consideration if they had active, concurrent non-thyroidal illness, psychiatric disease, known hypothalamic/pituitary lesions, were under treatment for hyper- or hypothyroidism, were on drugs known to affect TSH levels, or were pregnant. Patients without exclusions were diagnosed with free T3 toxicosis if they had: (1) a markedly subnormal TSH level (less than or equal to 0.1 mU/L), (2) a normal free T4, (3) a normal total T3, (4) evidence of a primary thyroid abnormality (e.g., autonomous function on a thyroid scan), and (5) an elevated free T3 level by tracer equilibrium dialysis. Patients meeting conditions 1-4, but with normal free T3 levels, were considered to have subclinical hyperthyroidism.Results One thousand twenty-five patients had TSH and simultaneous free T4 determinations, and 148 of these had markedly subnormal TSH but normal free T4 levels. Three patients met the criteria for free T3 toxicosis and three had subclinical hyperthyroidism. All six patients had either multinodular glands or a single nodule on thyroid exam. Four patients were treated with radioactive iodine or surgery, resulting in reversal of the TSH suppression in three cases.Conclusion Apparently healthy ambulatory patients with subnormal TSH levels should be worked up with measurements of free T4 and total T3. If these are normal, a T3 level (by tracer equilibrium dialysis) be obtained to distinguish subclinical hyperthyroidism from overt free T3 toxicosis. A thyroid scan and radioiodine uptake measurement can be obtained to substantiate the diagnosis. Some patients with these conditions will benefit from treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In hyperthyroidism, circulating T3 increases before T4, so analysis of T3 can provide clinically relevant information in patients with suppressed TSH.
“In hyperthyroidism, circulating T3 increases before T4. Consequently, the analysis of T3 can provide clinically relevant information in patients with suppressed TSH.”
In patients with undetectable serum TSH levels and normal FT4 and TT3 levels, FT3 evaluation can distinguish subclinical hyperthyroidism from overt FT3 toxicosis.
“In these patients with undetectable serum TSH levels and normal FT 4 and TT 3 levels, FT 3 (by tracer equilibrium dialysis) evaluation can distinguish SHyper from overt FT 3 toxicosis [17] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [17]
The citation lists haven’t been fetched yet
References 24 · Cited by 55
- Authors
- Figge, J., Leinung, M., Goodman, A. D., Izquierdo, R., Mydosh, T., Gates, S., Line, B., & Lee, D. W.
- Affiliations
- Albany Medical College (US)
- Albany Stratton VA Medical Center Albany (US)
- Corresponding author
- Figge, James
- ORCID
- Izquierdo, Roberto
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1994-03
- Volume
- 96
- Issue
- 3
- Pages
- 229-234
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1969789029
- Cited by
- 55
- References
- 24
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 6 · 2015: 2 · 2013: 1 · 2012: 8
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hd000975-02)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD00975)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- subclinical hyperthyroidism, free T3, thyroid-stimulating hormone, free thyroxine, autonomous thyroid function, multinodular goiter, thyroid nodules, radioiodine therapy, thyroidectomy, TSH suppression, thyroid scintigraphy, radioiodine uptake
- MeSH terms
- Adult, Aged, Ambulatory Care, Diagnosis, Differential, Female, Humans, Hyperthyroidism, Male, Middle Aged, Retrospective Studies, Thyroid Function Tests, Thyrotoxicosis, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review